A view from the EULAR Standing Committee of People with Arthritis/Rheumatism in Europe (SCPARE) on some of the issues that patients might wish to consider about biosimilars in shared decision-making discussions with their rheumatologist. The paper also points to the need for more information on biosimilars being made available in lay language.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623364 | PMC |
| http://dx.doi.org/10.1136/rmdopen-2015-000141 | DOI Listing |
Publication Analysis
Top Keywords
biosimilars patients
4
patients consider?
4
consider? view
4
view eular
4
eular standing
4
standing committee
4
committee people
4
people arthritis/rheumatism
4
arthritis/rheumatism europe
4
europe scpare
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!